- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01294995
Effect of Short-term Chinese Tea-flavor Liquor Consumption (ESTCTFLC)
Phase 1 Study of Chinese Tea-flavor Liquor
Human studies of Chinese liquor are sparse. The investigators hypothesize that short-term Chinese Tea-flavor liquor (TFL) consumption may be beneficial to inflammation biomarkers and CVD risk factors. Guizhou Meijiao Liquor (GML) is a traditional Chinese liquor, fermented from sorghum, corn, sticky rice, wheat and rice, while TFL is a novel Chinese liquor fermented from above 5 grains plus green tea.
Forty-five volunteers(23 males, 22 females) were selected to participate a paralleled randomized trial drinking 30 mL two kinds of Chinese liquors: TFL and GML respectively with meal every day for 28 days. Serums of volunteers were collected for analyzing serum lipids, inflammation biomarkers and CVD risk factors.
TFL could significantly decrease systolic blood pressure of males, but increase diastolic blood pressure of females. TFL could also decreased blood lipid of volunteers, especially for females. Both liquor significantly decrease serum uric acid and glucose in males and females. The effect of the two liquors on inflammation biomarkers were complicated and needs further research work.
TFL may possess more beneficial effect on CVD risk factors than GML probably because of the special fermentation products of green tea with other grains.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310029
- Department of Food Science and Nutrition
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy male and female volunteers
Exclusion Criteria:
- Subjects with a history of liver disease, diabetes, or heart disease
- Smokers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tea-flavor Liquor, taken with meal
including 12 males and 11 females
|
30 mL of Tea-flavor Liquor(45% alcohol content)
|
|
Placebo Comparator: Guizhou Meijiao Liquor, taken with meal
including 11 males and 11 females
|
30 mL of Guizhou Meijiao Liquor (45% alcohol content)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ST Chinese liquor study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Tea-flavor Liquor
-
Zhejiang UniversityGuizhou Meijiao Co., Ltd, ChinaCompletedCardiovascular Diseases | AlcoholsChina
-
Fontem US LLCFontem Ventures BVCompletedHealthy VolunteersUnited States
-
RWTH Aachen UniversityUnknownAneurysmal Subarachnoid HemorrhageGermany
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); University of MinnesotaCompletedTobacco Use DisorderUnited States
-
University of PennsylvaniaCompletedTobacco Use | Cigar SmokingUnited States
-
University of Roma La SapienzaAUSL LatinaNot yet recruitingCognitive Impairment | Normal Pressure HydrocephalusItaly
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedCigarette Smoking | Sex Differences | Nicotine Addiction | E-Cig UseUnited States
-
Federico II UniversityCompletedSmoking | Age Problem | Weight, Body
-
Monell Chemical Senses CenterHVMN (funding; holder of primary Department of Defense STTR contract)CompletedFlavor Perception in Normal, Healthy AdultsUnited States
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA)RecruitingOpioid Use Disorder | Nicotine Use DisoderUnited States